ACC 22 Late-breaker Discussion: The DIAMOND Trial

Published: 26 Apr 2022

  • Views:

    Views Icon 837
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) talked with Prof Faiez Zannad (University of Lorraine, FR) and Dr Javed Butler (University of Mississippi & Baylor University Medical Center, US) about the DIAMOND trial in a context of RAAS inhibition in HFrEF (NCT03888066).
First presented first at ACC.22, the trial investigated the effects of patiromer compared with placebo on serum K+ in heart failure patients.

Recorded remotely in Texas, Hamilton and Nancy, 2022. 

Editor: Mirjam Boros

Videography:Oliver Miles